Site Search

Please join us for the 6th annual New Mexico Cancer Summit. The 2019 NM Cancer Summit will examine the direct and indirect costs of cancer care during the patient journey. We will explore how benefit design, treatment plans and modalities, geographic location and other factors affect cancer patient costs and discuss what state and federal policymakers can do to help people maintain adequate and affordable access to care. PROGRAM MODERATOR: Dr. Jean McDougall, Assistant Professor, Department of Internal Medicine, University of New Mexico FEATURED GUEST SPEAKER: ... or 505-262-6019. Champion Sponsors: Bristol-Myers Squibb, Pfizer Community Sponsors: Celgene, Genentech, Janssen Oncology, PhRMA, Presbyterian Health Services In-Kind Sponsor: Resources for Change, Inc.     Contributions or membership payments to the American Cancer Society Cancer Action ...

... survivors, and their families. He was fiercely committed to racial and social justice, and as part of that work, to making sure access to health care was a basic human right. “In addition to playing a pivotal role in the civil rights movement, Rep. Lewis had long been a champion of cancer issues from his work on the Atlanta City Council throughout his time in Congress. The congressman recognized racism is a public health issue and was a vocal advocate for the passage of critical patient protections in the Affordable Care Act. “This year, an estimated 1.8 ...

... vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s numerous provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out ... A portion of the bill’s estimated savings would be directed to increasing federal investment in medical research at the National Institutes of Health (NIH) and extending funding for the Cancer Moonshot Initiative at the National Cancer Institute (NCI). The following is a statement from ... a cancer drug in 2017 hit the catastrophic cap in just the first two months of the year, according to research done for ACS CAN by Avalere Health. Rather than requiring full payment upfront, we support allowing those patients with high-cost drugs to space out their prescription drug ...

... teamed up to sponsor this important next step in ensuring cancer patients have access to precision medicine. The UC system is a leader in cancer care through the UC Cancer Consortium which comprises five of the nation's 51 National Cancer Institute-designated Comprehensive Cancer Centers. ... cancer diagnosis across the state on an equitable basis,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the opportunity to be among the leaders in the nation with this legislation.” Despite its benefits, access to biomarker ... due to several factors, including low awareness of new testing methodologies among providers and patients and lack of coverage by private health insurance and Medicaid programs. “Biomarker testing and precision medicine have led to improved patient survival and quality of life,” ...